JPS5134194A - - Google Patents

Info

Publication number
JPS5134194A
JPS5134194A JP50081475A JP8147575A JPS5134194A JP S5134194 A JPS5134194 A JP S5134194A JP 50081475 A JP50081475 A JP 50081475A JP 8147575 A JP8147575 A JP 8147575A JP S5134194 A JPS5134194 A JP S5134194A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50081475A
Other languages
Japanese (ja)
Other versions
JPS5250800B2 (nl
Inventor
Zeederu Arufuonsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS5134194A publication Critical patent/JPS5134194A/ja
Publication of JPS5250800B2 publication Critical patent/JPS5250800B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
JP50081475A 1974-07-05 1975-07-03 Expired JPS5250800B2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (2)

Publication Number Publication Date
JPS5134194A true JPS5134194A (nl) 1976-03-23
JPS5250800B2 JPS5250800B2 (nl) 1977-12-27

Family

ID=27048497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50081475A Expired JPS5250800B2 (nl) 1974-07-05 1975-07-03

Country Status (14)

Country Link
JP (1) JPS5250800B2 (nl)
AR (1) AR210330A1 (nl)
AT (1) AT339917B (nl)
CA (1) CA1062710A (nl)
CH (2) CH622519A5 (nl)
DK (1) DK140214B (nl)
ES (1) ES439141A1 (nl)
FI (1) FI59249C (nl)
FR (1) FR2277089A1 (nl)
GB (1) GB1500039A (nl)
LU (1) LU72897A1 (nl)
NL (1) NL166476C (nl)
NO (1) NO143224C (nl)
SE (2) SE420097B (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
JPS5250800B2 (nl) 1977-12-27
SE427183B (sv) 1983-03-14
NL166476B (nl) 1981-03-16
ES439141A1 (es) 1977-02-16
DK140214B (da) 1979-07-09
FI59249B (fi) 1981-03-31
CH622519A5 (en) 1981-04-15
NO143224C (no) 1981-01-02
NO143224B (no) 1980-09-22
FR2277089A1 (fr) 1976-01-30
NO752423L (nl) 1976-01-06
CH622018A5 (en) 1981-03-13
GB1500039A (en) 1978-02-08
AT339917B (de) 1977-11-10
DK301775A (nl) 1976-01-06
SE7507726L (sv) 1976-01-06
DK140214C (nl) 1979-12-03
FI751958A (nl) 1976-01-06
AU8275575A (en) 1977-01-06
SE420097B (sv) 1981-09-14
SE7807853L (sv) 1978-07-14
FI59249C (fi) 1981-07-10
CA1062710A (en) 1979-09-18
NL166476C (nl) 1981-08-17
ATA517275A (de) 1977-03-15
FR2277089B1 (nl) 1978-03-17
AR210330A1 (es) 1977-07-29
LU72897A1 (nl) 1976-05-31
NL7507976A (nl) 1976-01-07

Similar Documents

Publication Publication Date Title
JPS50101386A (nl)
FR2277762B2 (nl)
FR2292368B1 (nl)
FI753332A (nl)
FR2277089B1 (nl)
FR2294895B1 (nl)
JPS50141392U (nl)
JPS50108927A (nl)
JPS50158831A (nl)
JPS50139578A (nl)
AR198461Q (nl)
JPS50133535U (nl)
CS169593B1 (nl)
BG19663A1 (nl)
CH579976A5 (nl)
CH571443A5 (nl)
AU480879A (nl)
BG27049A3 (nl)
BG21540A1 (nl)
CH581571A5 (nl)
AU481723A (nl)
CH450474A4 (nl)
BG21143A1 (nl)
CH582212A5 (nl)
CH581874A5 (nl)